RD
Richard Elliot Doblin is an American psychedelic drug advocate who is the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS).
Across 1 conversation, Rick Doblin ranges across psychedelics, MDMA, PTSD. MAPS has raised about $110 million over 35 years to integrate psychedelics into therapeutic practices. MDMA-assisted therapy shows a 67% PTSD remission rate for the dissociative subtype, outperforming traditional therapies.
Synthesized by TLexDR from 1 conversation. AI-generated. Report an inaccuracy
The idea map
Rick's intellectual territory
Click a star to read the quotes and jump into the episode.
For the specialist
previewMDMA-assisted therapy's 67% remission rate for the dissociative subtype of PTSD suggests it could be more effective than traditional treatments.
#202Rick Doblin: Psychedelics
The statistical significance of 0.0001 in MDMA studies indicates a robust effect, challenging the skepticism around psychedelic therapy.
#202Rick Doblin: Psychedelics
The appearance
Every conversation, in order
Reading list
What they pointed you toward
books
papers
Every idea, by region
The full territory
PTSD
PTSDAdjacent minds